Atlas Trials

A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder

Clinical trial NCT02234011 · TERMINATED

Trial details

NCT number
NCT02234011
Sponsor
Mclean Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2014-09-01
Primary completion
2016-01-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.